Latanoprost Viatris

Latanoprost, the active ingredient in Latanoprost Viatris, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is used to manage open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog that reduces intra‑ocular pressure in glaucoma‑related conditions. - Open‑angle glaucoma: lowers intra‑ocular pressure to slow optic nerve damage. - Ocular hypertension: reduces elevated eye pressure to prevent progression to glaucoma. - Elevated intra‑ocular pressure: helps maintain normal pressure levels and protect visual function.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual pigmentation change. - Eye irritation: burning or stinging sensation. - Blurred vision: temporary visual disturbance. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Increased intra‑ocular pressure: paradoxical rise requiring medical attention. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea affecting clarity. - Severe allergic reaction: swelling, itching, or rash around the eye. - Persistent eye pain: may indicate underlying complication.

Before using Latanoprost, consider the following safety measures. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; use with caution. - Hypersensitivity: discontinue if allergic reaction occurs. - Monitoring: regular intra‑ocular pressure checks are essential. - Concomitant prostaglandin analogs: avoid simultaneous use to prevent additive effects. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Other prostaglandin analog eye drops: may cause excessive pressure reduction. - Cycloplegic agents: can diminish Latanoprost efficacy. - Ocular anesthetics: may increase systemic absorption.

Moderate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory eye drops: may alter prostaglandin pathways. - Beta‑blocker eye drops: additive IOP‑lowering effect, monitor pressure. - Systemic carbonic anhydrase inhibitors: watch for excessive pressure drop.